It is not clear whether GNA13 also regulates the expression of BCL2 in tumors other than GCB-DLBCL and whether the therapeutic scenario for targeting palmitoylation of GNA13 in combination with the BCL2 inhibitor holds in other types of cancer. The gene discussed is GNA13; the disease is cancer.